Ensysce Biosciences Performance
The firm shows a Beta (market volatility) of 0.0, which means not very significant fluctuations relative to the market. the returns on MARKET and Ensysce Biosciences are completely uncorrelated.
Risk-Adjusted Performance
Weakest
Weak | Strong |
Over the last 90 days Ensysce Biosciences has generated negative risk-adjusted returns adding no value to investors with long positions. Even with relatively invariable fundamental indicators, Ensysce Biosciences is not utilizing all of its potentials. The recent stock price agitation, may contribute to short-term losses for the retail investors. ...more
| Quick Ratio | 0.06 | |
| Fifty Two Week Low | 10.11 | |
| Fifty Two Week High | 23.99 |
Ensysce |
Ensysce Biosciences Relative Risk vs. Return Landscape
If you would invest (100.00) in Ensysce Biosciences on October 19, 2025 and sell it today you would earn a total of 100.00 from holding Ensysce Biosciences or generate -100.0% return on investment over 90 days. Ensysce Biosciences is currently does not generate positive expected returns and assumes 0.0% risk (volatility on return distribution) over the 90 days horizon. In different words, 0% of pink sheets are less volatile than Ensysce, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
Ensysce Biosciences Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Ensysce Biosciences' investment risk. Standard deviation is the most common way to measure market volatility of pink sheets, such as Ensysce Biosciences, and traders can use it to determine the average amount a Ensysce Biosciences' price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.0
| High Returns | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| LACQ |
Based on monthly moving average Ensysce Biosciences is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Ensysce Biosciences by adding Ensysce Biosciences to a well-diversified portfolio.
Ensysce Biosciences Fundamentals Growth
Ensysce Pink Sheet prices reflect investors' perceptions of the future prospects and financial health of Ensysce Biosciences, and Ensysce Biosciences fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Ensysce Pink Sheet performance.
| Return On Equity | 23.4 | |||
| Return On Asset | -1.25 | |||
| Current Valuation | 90.07 M | |||
| Shares Outstanding | 6.22 M | |||
| Price To Earning | 118.69 X | |||
| Price To Book | 47.63 X | |||
| EBITDA | 2.39 M | |||
| Cash And Equivalents | 18.03 K | |||
| Total Debt | 460 K | |||
| Debt To Equity | 0.24 % | |||
| Book Value Per Share | 0.30 X | |||
| Cash Flow From Operations | (896.22 K) | |||
| Earnings Per Share | 0.12 X | |||
| Total Asset | 183.27 M | |||
| Retained Earnings | 2.16 M | |||
| Current Asset | 1.71 M | |||
| Current Liabilities | 391.79 K |
Things to note about Ensysce Biosciences performance evaluation
Checking the ongoing alerts about Ensysce Biosciences for important developments is a great way to find new opportunities for your next move. Pink Sheet alerts and notifications screener for Ensysce Biosciences help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Ensysce Biosciences is not yet fully synchronised with the market data | |
| Ensysce Biosciences has some characteristics of a very speculative penny stock | |
| Ensysce Biosciences has a very high chance of going through financial distress in the upcoming years | |
| Ensysce Biosciences currently holds 460 K in liabilities with Debt to Equity (D/E) ratio of 0.24, which may suggest the company is not taking enough advantage from borrowing. Ensysce Biosciences has a current ratio of 0.7, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Debt can assist Ensysce Biosciences until it has trouble settling it off, either with new capital or with free cash flow. So, Ensysce Biosciences' shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Ensysce Biosciences sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Ensysce to invest in growth at high rates of return. When we think about Ensysce Biosciences' use of debt, we should always consider it together with cash and equity. | |
| Ensysce Biosciences currently holds about 18.03 K in cash with (896.22 K) of positive cash flow from operations. | |
| Roughly 57.0% of Ensysce Biosciences shares are owned by institutional investors |
- Analyzing Ensysce Biosciences' financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Ensysce Biosciences' stock is overvalued or undervalued compared to its peers.
- Examining Ensysce Biosciences' industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Ensysce Biosciences' management team can have a significant impact on its success or failure. Reviewing the track record and experience of Ensysce Biosciences' management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Ensysce Biosciences' pink sheet. These opinions can provide insight into Ensysce Biosciences' potential for growth and whether the stock is currently undervalued or overvalued.
Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in unemployment. You can also try the Idea Optimizer module to use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio .
Other Consideration for investing in Ensysce Pink Sheet
If you are still planning to invest in Ensysce Biosciences check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Ensysce Biosciences' history and understand the potential risks before investing.
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings |